Jan 5, 2026 by David DierkingIs the Vanguard Russell 2000 ETF a Buy Now?Large caps and tech stocks have dominated the market over the past three years. Is now the time for a small-cap comeback?
Jan 5, 2026 by David DierkingIf You'd Thrown $1,000 at the SPDR S&P 500 ETF 33 Years Ago, Here's the Jaw-Dropping Amount You'd Have NowEven with the bear markets and recessions, the SPDR S&P 500 ETF (SPY) has produced quadruple-digit returns over its lifetime.
Jan 5, 2026 by Katie BrockmanShould You Invest in the Stock Market in 2026? Here's Warren Buffett's Best Advice.The answer is simpler than you might think.
Jan 5, 2026 by TMF Breakfast NewsBreakfast News: 2026 Earnings Kick OffFool favorites reporting, oil stocks get a boost, it's CES time again, and more...
Jan 5, 2026 by Keith SpeightsNearly 65% of Warren Buffett's Portfolio Is Invested in These 5 Stocks as 2026 BeginsBuffett's favorite stocks remain Berkshire's biggest holdings even after he passed the torch to his successor.
Jan 5, 2026 by Selena MaranjianIs This One of the Best ETFs to Buy Right Now?If you're bullish on the spread of artificial intelligence (AI) and the growth of energy-eating data centers, this ETF may be for you.
Jan 5, 2026 by Anthony Di PizioHere's When the Federal Reserve Is Expected to Cut Interest Rates in 2026, and What It Means for the Stock MarketHistory suggests lower interest rates are great for stocks, but there's an important catch.
Jan 5, 2026 by Keith Speights26 Top Dividend Stocks to Buy and Hold in 2026Another year, another long list of great dividend stocks.
Jan 5, 2026 by Trevor JennewineWill the Stock Market Crash in 2026? The Federal Reserve Has a Warning for Investors.Several Federal Reserve officials have commented on the stock market's elevated valuation.
Jan 4, 2026 by Robert IzquierdoBetter Dividend ETF: Vanguard's VYM vs. ProShares' NOBLExpense-conscious investors weighing sector breadth and portfolio focus will find key differences between these two dividend ETFs.
Jan 4, 2026 by Sara AppinoVDC vs. RSPS: Broad Diversification or Balanced Bets for Consumer Staples Investors? Lower fees helped VDC outperform RSPS by over 2% in the last year, but equal weighting offers better diversification.
Jan 4, 2026 by Sara Appino2,400 Stocks or 315 Value Picks: Is SCHB or VTV a Better Fit for Your Portfolio?SCHB owns the whole market, while VTV focuses on value bargains.
Jan 4, 2026 by David DierkingWill the Nasdaq 100 ETF Triple Your Money in the Next 10 Years?The Invesco QQQ Trust (QQQ) has been a stellar performer for more than two decades. Can the next decade produce a repeat?
Jan 4, 2026 by Neha ChamariaThe Ultimate Dividend ETF Face-Off: SCHD's High Yield vs. NOBL's Dividend GrowthExpense ratios, sector tilts, and dividend strategies set these two popular ETFs apart for investors seeking the right portfolio fit.
Jan 4, 2026 by Josh Kohn-LindquistRWX vs. HAUZ: Which International Real Estate ETF Is the Better Buy?Key differences in fees, yield, and portfolio strategy set RWX and HAUZ apart for investors seeking international real estate exposure.
Jan 4, 2026 by Selena MaranjianIf You'd Invested $1,000 in the Utilities Select Sector SPDR Fund (XLU) 10 Years Ago, Here's How Much You'd Have TodayAn alternative investment would have performed better.
Jan 4, 2026 by Robert IzquierdoBetter Broad-Market ETF: Schwab's SCHB vs. iShares' ITOTWith similar holdings and costs, the real differences between these two broad-market ETFs come down to scale and trading activity.
Jan 4, 2026 by Katie BrockmanShould You Really Invest in AI Stocks in 2026? Here's What Other Investors Are SayingIs AI headed for a bubble? Or is there still room for growth?
Jan 4, 2026 by Sean WilliamsWill the Stock Market Skyrocket in 2026 Under President Donald Trump? A Historically Flawless Correlation Will Be Put to the Test.A 75-year correlation with a perfect track record suggests Wall Street's benchmark index will soar more than 20% in the new year.
Jan 4, 2026 by Daniel Foelber4 Stocks to Buy in January That Could Join Nvidia in the $1 Trillion Club by 2030Visa, ExxonMobil, Oracle, and Netflix have multi-year compounding potential for patient investors.